Journal Article

From 2010 to 2013, RAND conducted a program evaluation of the Substance Abuse and Mental Health Services Administration's Primary and Behavioral Health Care Integration (PBHCI) grants program, describing the structure, process, and outcomes for the first three cohorts of grantee programs (awarded in 2009 and 2010). The current study extends previous work by investigating the impact of PBHCI on consumers' healthcare use, total costs of care to Medicaid, and quality of care in three States

Aims to determine the proportion and characteristics of adults in primary care who screen positive for unhealthy substance use one or more years after screening negative

Describes the methodology of a study that aims to test a 6-month practice facilitation for managing unhealthy alcohol use in Veterans Health Administration liver clinics

This study evaluates the test-retest reliability of a patient-report Alcohol Symptom Checklist questionnaire when it is used in routine care, including primary care and mental health specialty settings, suggesting that the Alcohol Symptom Checklist may be a valuable tool in supporting treatment and care of patients with alcohol use disorder

Examines the impact of implementation of an Alcohol Symptom Checklist in identifying primary care patients with alcohol use disorder, finding that checklists can be helpful with diagnosis and treatment

Systematically reviews 156 trials, finding the best evidence of effectiveness for acamprosate, disulfiram, baclofen, and oral naltrexone among patients with alcohol use disorder supporting the expanded use of these medications in the clinical setting

Qualitative literature review that discusses disulfiram, acamprosate, naltrexone, nalmefene, topiramate, gabapentin, and several other medications for the treatment of alcohol use disorder, which have demonstrated some clinical effectiveness

A review of the literature on clinical trials on pharmacotherapies for alcohol use disorder, noting that topiramate and gabapentin have been used and that baclofen and nalmefene have been approved in some other countries

Reviews the literature and data on outcomes for medication-assisted treatment for alcohol use disorder in inpatient settings using naltrexone

This study aimed to systematically review and synthesize the research evidence about the efficacy of mHealth interventions on various health outcomes for consumer self-control of unhealthy alcohol use and to identify the core components to achieve these outcomes